Anixa Biosciences Analyst Ratings
BenzingaMar 21 06:31 ET
Anixa Biosciences: A Buy Rating on Strong Financials and Promising Oncology Advances
TipRanksMar 21 06:17 ET
Analysts Conflicted on These Healthcare Names: Anixa Biosciences (ANIX) and InMode (INMD)
TipRanksFeb 13 12:20 ET
Anixa Biosciences Analyst Ratings
BenzingaFeb 13 12:18 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaDec 7, 2023 06:28 ET
Anixa Biosciences Analyst Ratings
BenzingaDec 7, 2023 06:26 ET
Buy Rating for Anixa Biosciences Backed by Strong Patent Position and Promising CAR-T Therapy Trial Results
TipRanksNov 28, 2023 11:15 ET
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX) and Amylyx Pharmaceuticals Inc (AMLX)
TipRanksOct 16, 2023 06:41 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaSep 18, 2023 12:19 ET
Anixa Biosciences Analyst Ratings
BenzingaSep 18, 2023 12:18 ET
Anixa Biosciences (ANIX) Receives a Buy From H.C. Wainwright
TipRanksSep 18, 2023 12:15 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaAug 29, 2023 06:12 ET
Anixa Biosciences Analyst Ratings
BenzingaAug 29, 2023 06:12 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaJul 28, 2023 09:42 ET
Anixa Biosciences Analyst Ratings
BenzingaJul 28, 2023 09:41 ET
Analysts Offer Insights on Healthcare Companies: Anixa Biosciences (ANIX), Roche Holding AG (OtherRHHVF) and Bristol-Myers Squibb (BMY)
TipRanksJul 28, 2023 09:40 ET
H.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)
TipRanksJul 12, 2023 06:15 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaJul 12, 2023 06:07 ET
Anixa Biosciences Analyst Ratings
BenzingaJul 12, 2023 06:06 ET
HC Wainwright & Co. Reiterates Buy on Anixa Biosciences, Maintains $12 Price Target
BenzingaJun 19, 2023 04:05 ET
No Data
No Data